Text Size

Evaluation of Tak Community Advisory Board

This study is currently recruiting participants.
Verified October 2012 by University of Oxford
Sponsor:
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT01719965
First received: October 17, 2012
Last updated: October 30, 2012
Last verified: October 2012
History of Changes
  Purpose

A popular form of community engagement is for the researchers to interact with a Community Advisory Board. The Shoklo Malaria Research Unit has been working on the Thai-Burmese border for many years and has been informally engaging with the community for its healthcare and research initiatives, especially in the area of ethics and consent. In January 2009, community engagement was formalised with the establishment of the Tak Province Border Community Ethics Advisory Board (T-CAB). The T-CAB is the first of its kind as the investigators have not come across any set up of similar nature involving mobile and unstable populations residing along a porous border.

Three years on, SMRU questions if the T-CAB has been "successful" and if the current T-CAB model is the best model for this community. In order to evaluate the T-CAB, first an evaluation tool has to be developed as there are no off-the-shelf evaluation tools for CABs, then the evaluation will be carried out.


Condition Intervention
Community Members
 Other: Interviews and Focus Group Discussions

Study Type: Observational
Official Title: Evaluation of the Tak Province Community Ethics Community Advisory Board: Interviews and Focus Group Discussions

Further study details as provided by University of Oxford:

Primary Outcome Measures:
  • Qualitative Assessment of Community Advisory Board. A summary of opinions raised in interviews. [ Time Frame: 90 Minutes ] [ Designated as safety issue: No ]
    Individual interviews and Focus Group Discussions. This is an observational study and the outcomes will be the comments the investigators receive from participants. The investigators will bring these views together and highlight general views and any particular points of note or problems identified by participants.


Estimated Enrollment: 45
Study Start Date: October 2012
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Health Workers
  • Worked in SMRU for at least 6 months
  • Clinic assistants, medics or home visitors
 Other: Interviews and Focus Group Discussions
Researchers
  • Worked in SMRU for at least 6 months
  • Physician or scientist
 Other: Interviews and Focus Group Discussions
CAB members
- Member of the CAB for at least 3 months
 Other: Interviews and Focus Group Discussions
Community members
- Lived in the border area (area served by SMRU or Mae Sot) for at least 6 months
 Other: Interviews and Focus Group Discussions
Research subjects
- Participants who are currently enrolled in an SMRU study
 Other: Interviews and Focus Group Discussions

  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Community members who work in Tak Province, Thailand.

Criteria

Inclusion Criteria:

A. Health workers

  • Worked in SMRU for at least 6 months
  • Clinic assistants, medics or home visitors

B. Researchers

  • Worked in SMRU for at least 6 months
  • Physician or scientist

C. CAB members

- Member of the CAB for at least 3 months

D. Community members - Lived in the border area (area served by SMRU or Mae Sot) for at least 6 months

E. Research subjects

- Participants who are currently enrolled in an SMRU study

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01719965

Contacts
Contact: Phaik Yeong Cheah, PhD phaikyeong@tropmedres.ac

Locations
Thailand
Shoklo Malaria Research Unit Recruiting
Mae Sot, Tak, Thailand
Contact: Khin Maung Lwin, MD         drkhin_mg_lwin@shoklo-unit.com    
Principal Investigator: Khin Maung Lwin, MD            
Sponsors and Collaborators
University of Oxford
  More Information

No publications provided

Responsible Party: University of Oxford
ClinicalTrials.gov Identifier: NCT01719965     History of Changes
Other Study ID Numbers: CTSG1201
Study First Received: October 17, 2012
Last Updated: October 30, 2012
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by University of Oxford:
Community Advisory Board
Focus Group Discussion
Interview
Community Engagement
Thailand

ClinicalTrials.gov processed this record on May 19, 2013